These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26118895)

  • 21. Pathological classification of brain tumors.
    Pollo B
    Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):103-11. PubMed ID: 22617234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular diagnostics of gliomas: the clinical perspective.
    Tabatabai G; Stupp R; van den Bent MJ; Hegi ME; Tonn JC; Wick W; Weller M
    Acta Neuropathol; 2010 Nov; 120(5):585-92. PubMed ID: 20862485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multidisciplinar approach to the management of gliomas].
    Moura B; Migliorini D; Bourhis J; Daniel R; Levivier M; Hottinger AF
    Rev Med Suisse; 2016 Apr; 12(516):821-5. PubMed ID: 27281939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecularly based management of gliomas in clinical practice.
    Rudà R; Pellerino A; Magistrello M; Franchino F; Pinessi L; Soffietti R
    Neurol Sci; 2015 Sep; 36(9):1551-7. PubMed ID: 26194534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress in the application of molecular biomarkers in gliomas.
    Wang J; Su HK; Zhao HF; Chen ZP; To SS
    Biochem Biophys Res Commun; 2015 Sep; 465(1):1-4. PubMed ID: 26253473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular predictors of outcome in low-grade glioma.
    Weiler M; Wick W
    Curr Opin Neurol; 2012 Dec; 25(6):767-73. PubMed ID: 23160425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
    Plant-Fox AS; O'Halloran K; Goldman S
    Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy for malignant gliomas.
    Kyritsis AP
    Oncology (Williston Park); 1993 Sep; 7(9):93-100; discussion 103, 106. PubMed ID: 8217533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment.
    Rizzo D; Ruggiero A; Martini M; Rizzo V; Maurizi P; Riccardi R
    Biomed Res Int; 2015; 2015():215135. PubMed ID: 26448930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New treatment paradigm for patients with anaplastic oligodendroglial tumors.
    Polivka J; Polivka J; Rohan V; Topolcan O
    Anticancer Res; 2014 Apr; 34(4):1587-94. PubMed ID: 24692686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New frontiers in the treatment of malignant glioma.
    Macdonald DR
    Semin Oncol; 2003 Dec; 30(6 Suppl 19):72-6. PubMed ID: 14765391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas.
    Ngo TT; Peng T; Liang XJ; Akeju O; Pastorino S; Zhang W; Kotliarov Y; Zenklusen JC; Fine HA; Maric D; Wen PY; De Girolami U; Black PM; Wu WW; Shen RF; Jeffries NO; Kang DW; Park JK
    J Natl Cancer Inst; 2007 Apr; 99(8):639-52. PubMed ID: 17440165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glioma.
    Weller M; Wick W; Aldape K; Brada M; Berger M; Pfister SM; Nishikawa R; Rosenthal M; Wen PY; Stupp R; Reifenberger G
    Nat Rev Dis Primers; 2015 Jul; 1():15017. PubMed ID: 27188790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular subtypes of glioma identified by genome-wide methylation profiling.
    Kloosterhof NK; de Rooi JJ; Kros M; Eilers PH; Sillevis Smitt PA; van den Bent MJ; French PJ
    Genes Chromosomes Cancer; 2013 Jul; 52(7):665-74. PubMed ID: 23629961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers of clinical responsiveness in brain tumor patients : progress and potential.
    El-Jawahri A; Patel D; Zhang M; Mladkova N; Chakravarti A
    Mol Diagn Ther; 2008; 12(4):199-208. PubMed ID: 18652516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular Classification and Personalized Treatment of Gliomas].
    Sasaki H; Yoshida K
    No Shinkei Geka; 2016 Mar; 44(3):185-201. PubMed ID: 26965060
    [No Abstract]   [Full Text] [Related]  

  • 37. New treatment strategies for malignant gliomas.
    Sathornsumetee S; Rich JN
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
    Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular subclassification of diffuse gliomas: seeing order in the chaos.
    Huse JT; Phillips HS; Brennan CW
    Glia; 2011 Aug; 59(8):1190-9. PubMed ID: 21446051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.